The Latest Cardiac and Vascular News
Innovative AI Application Improves Cardiac Monitoring and Diagnostic Accuracy BELFAST, Northern Ireland , Jan. 11, 2024 /PRNewswire/ — PulseAI, a leader in artificial intelligence healthcare solutions, today announced a significant advancement in consumer device electrocardiogram (ECG)…
Caesarea, Israel – January 9, 2024 – Arineta Cardio Imaging, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, welcomes its new CEO Doug Ryan to its international team. Ryan brings 30 years of experience creating business infrastructure and crafting market strategies for medical device companies to his role […]
OXFORD, England, Jan. 10, 2024 /PRNewswire/ — Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with Pfizer to support the validation and FDA clearance of its AI-based technology for the…
TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it has received a No Objection Letter from Health Canada to conduct a Phase II trial for LSALT peptide, targeting the prevention and treatment of cardiac surgery-associated […]
DENVER–(BUSINESS WIRE)–Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the launch of Cleerly ISCHEMIA, which recently received U.S. Food and Drug Administration (FDA) 510(k) medical device clearance. Cleerly ISCHEMIA analysis software is an automated machine learning-based decision support tool, intended […]
WALTHAM, Mass.–(BUSINESS WIRE)–Paragonix Technologies, a pioneer in organ transplant solutions, is proud to announce the publication of new groundbreaking data reflecting the clinical impact of its flagship advanced preservation device, the Paragonix SherpaPak Cardiac Transport System (CTS), to protect and monitor donor hearts from extended criteria donors. In organ transplantation, an extended criteria donor is defined as having perceived risk factors linked to poor subsequent outcomes, for
IRVINE, Calif.–(BUSINESS WIRE)– Endologix Inc. LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that Scott Ward has been appointed to the Endologix Board of Directors. Scott Ward was most recently the CEO and Chairman of the […]
First regulatory approval for the first-of-its-kind, fully-integrated PFA system with a simple and reproducible workflow Integrated with the world’s leading CARTO™ 3D cardiac mapping system for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AFib)…
SAN FRANCISCO, CA – JANUARY 8, 2024 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that the company has surpassed adoption in 1,500 hospitals in the United States, including the majority of the 50 largest healthcare systems. The company’s user base grew in 2023 by […]
2023 reported preliminary unaudited revenue in the range of approximately $1.255 billion – $1.259 billion, up approximately 9.0% – 9.4% year-over-year 2023 preliminary unaudited constant currency revenue* in the range of up approximately 9.6% – 9.9% year over year 2023 financial results and 2024 guidance to be released February 28, […]
